The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

eyebrain.fr

Stage

Series C | Alive

Total Raised

$7.57M

Last Raised

$1.47M | 7 yrs ago

About EyeBrain

EyeBrain is developing brain function markers for neurological and psychiatric diseases utilizing devices based on eye motricity. They make it possible to test specific regions of the brain by recording and analyzing eye movements using sophisticated algorithms developed by the company. The devices developed by EyeBrain have filled a void in the devices used in neurology; they complete a standard clinical examination within 20 minutes and at a lower cost than imaging techniques (MRI, scanners). They are also non-invasive relative to other types of examination in standard use (lumbar punctures, blood tests).The Mobile EyeBrain Tracker (Mobile EBT) comes as a complete package that includes an eye-tracker, a chin rest, two screens and a computer, together with stimulation and analysis software. When used routinely in hospital, it already provides the doctor with information for the early characterization of Parkinsonian syndromes (AMS, PSP, CBD, etc.) and for monitoring multiple sclerosis. The EBT has obtained CE marking, while EyeBrain also has ISO 9001 and ISO 13485 certification. Eye motricity testing (eye tracking) is paid for by the French social security system.

EyeBrain Headquarter Location

1 bis, rue Jean le Galleu

Ivry-Sur-Seine, 94200,

France

+33 1 83 64 37 38

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing EyeBrain

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

EyeBrain is included in 4 Expert Collections, including Cannabis.

C

Cannabis

3,834 items

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

M

Medical Devices

8,373 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

H

Health IT

7,900 items

EyeBrain Patents

EyeBrain has filed 18 patents.

The 3 most popular patent topics include:

  • Ophthalmology
  • Vision
  • Optometry
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/31/2017

6/14/2022

Ophthalmology, Geometrical optics, Corrective lenses, Vision, Optometry

Grant

Application Date

12/31/2017

Grant Date

6/14/2022

Title

Related Topics

Ophthalmology, Geometrical optics, Corrective lenses, Vision, Optometry

Status

Grant

Latest EyeBrain News

eyeBrain Medical and IDOC Announce a Multiyear Partnership to Bring neurolens® Contoured Prism Lenses to IDOC Independent Optometrists

Feb 25, 2019

COSTA MESA, Calif., and NORWALK, Conn., Feb. 19, 2019 - IDOC and eyeBrain Medical today announced a multiyear partnership to bring breakthrough neurolens® prescription lenses to all IDOC members across the U.S. neurolenses are the first and only prescription lenses that add a contoured prism to bring the eyes into alignment. Contoured prisms have been shown in studiesi,iito relieve the headaches, neck/shoulder pain and eyestrain that many people experience when using digital devices, reading or doing detail work. As the leading independently owned optometric alliance in the U.S., IDOC offers a suite of programs and service that empowers its members to grow and succeed. The partnership with eyeBrain aligns with IDOC’s long-term strategy of bringing meaningful and differentiated offerings to its independent optometrist members, helping them create unique areas of expertise in their communities.

  • Where is EyeBrain's headquarters?

    EyeBrain's headquarters is located at 1 bis, rue Jean le Galleu, Ivry-Sur-Seine.

  • What is EyeBrain's latest funding round?

    EyeBrain's latest funding round is Series C.

  • How much did EyeBrain raise?

    EyeBrain raised a total of $7.57M.

  • Who are the investors of EyeBrain?

    Investors of EyeBrain include Fonds Regional de Co-Investissement d'lle-France, Karista, G1J Ile-de-France, Octalfa, CM-CIC Capital Finance and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.